FFO
EW icon

Fortitude Family Office’s Edwards Lifesciences EW Stock Holding History

Fortitude Family Office’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Sell
236
-54
-19% -$4.52K ﹤0.01% 506
2026
Q1 		$23.2K Buy
290
+55
+23% +$4.53K 0.01% 395
2025
Q4 		$20K Sell
235
-14
-6% -$1.15K ﹤0.01% 404
2025
Q3 		$19.4K Buy
249
+40
+19% +$3.13K 0.01% 403
2025
Q2 		$16.3K Buy
209
+113
+118% +$8.43K 0.01% 415
2025
Q1 		$6.96K Hold
96
– – ﹤0.01% 639
2024
Q4 		$7.11K Sell
96
-132
-58% -$9.24K ﹤0.01% 729
2024
Q3 		$15K Sell
228
-35
-13% -$2.54K 0.01% 479
2024
Q2 		$24.3K Buy
263
+35
+15% +$3.1K 0.01% 271
2024
Q1 		$21.8K Hold
228
– – 0.01% 264
2023
Q4 		$17.4K Buy
+228
New +$15.9K 0.01% 321

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Fortitude Family Office's EW Position: Q2 2026 in Review

Fortitude Family Office reduced its Edwards Lifesciences (EW) stake by 19% in Q2 2026, selling an estimated $4.52K and leaving 236 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Fortitude Family Office first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $24.3K in Q2 2024. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Fortitude Family Office held 236 shares of Edwards Lifesciences worth $21.3K as of Q2 2026.
  • Fortitude Family Office sold 54 Edwards Lifesciences shares in Q2 2026, an estimated $4.52K.
  • Edwards Lifesciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #506 holding.
  • Fortitude Family Office first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • Fortitude Family Office's Edwards Lifesciences position peaked at $24.3K in Q2 2024.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.